Effectiveness of Mindfulness-Based Relapse Prevention for Co-occurring Substance Use and Depression Disorders

Zemestani, Mehdi; Ottaviani, Cristina

doi:10.1007/s12671-016-0576-y

Cited by 36 publications

(45 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On the one hand, the most common inclusion criteria were (1) 18 years old or older; (2) English fluency; (3) meeting diagnostic criteria for SUD and other BAs (e.g., gambling disorder); (4) medical clearance; and (5) willingness to be randomized. However, several trials showed other or different inclusion criteria: (1) residency at the treatment center or therapeutic community ( 20 , 30 , 37 ); (2) to be able to speak and read Persian ( 53 ); (3) to be 18–29 ( 40 , 50 ), 18–20 ( 42 ), 14 or older ( 48 ), 18–40 ( 33 ), 20–45 ( 41 ), and 21–29 years old ( 54 ); (4) living in low socioeconomic areas ( 55 ); (5) recurrent pain ( 56 , 57 ); (6) adult with mild intellectual disability ( 52 ), and (7) having participated in a school-based intervention program ( 58 ). Furthermore, there were studies which did not provide these data ( 35 , 44 , 47 , 59 – 63 ).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review

et al. 2018

View full text Add to dashboard Cite

BackgroundEmotion (dys)regulation as well as the interventions for improving these difficulties are receiving a growing attention in the literature. The aim of the present paper was to conduct a systematic review about the efficacy of mindfulness-based interventions (MBIs) in both substance and behavioral addictions (BAs).MethodA literature search was conducted using Cochrane, PubMed, and Web of Science. Fifty-four randomized controlled trials published in English since 2009 to April 2017 were included into a narrative synthesis.ResultsMindfulness-based interventions were applied in a wide range of addictions, including substance use disorders (from smoking to alcohol, among others) and BAs (namely, gambling disorder). These treatments were successful for reducing dependence, craving, and other addiction-related symptoms by also improving mood state and emotion dysregulation. The most commonly used MBI approaches were as follows: Mindfulness-Based Relapse Prevention, Mindfulness Training for Smokers, or Mindfulness-Oriented Recovery Enhancement, and the most frequent control group in the included studies was Treatment as Usual (TAU). The most effective approach was the combination of MBIs with TAU or other active treatments. However, there is a lack of studies showing the maintenance of the effect over time. Therefore, studies with longer follow-ups are needed.ConclusionThe revised literature shows support for the effectiveness of the MBIs. Future research should focus on longer follow-up assessments as well as on adolescence and young population, as they are a vulnerable population for developing problems associated with alcohol, drugs, or other addictions.

show abstract

Section: Resultsmentioning

confidence: 99%

“…The most frequent mindfulness interventions (Table 1 ) were MBRP ( 19 , 36 , 37 , 45 , 53 , 60 , 61 , 68 – 72 ), MTS ( 50 , 55 , 73 – 75 ), MORE ( 20 , 30 , 43 , 56 , 57 ), ACT and variations ( 42 , 62 , 64 , 66 ), and different types of Yoga ( 31 , 47 , 48 ).…”

Section: Resultsmentioning

confidence: 99%

Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review

et al. 2018

View full text Add to dashboard Cite

show abstract

“…MBRP embodies a combination of CBT and mindfulness medication techniques and aims to help improve coping mechanisms and decrease risk of relapse for patients with methamphetamine and other substance use disorders (X. J. Chen et al, ). MBRP methods have been shown to decrease craving and depressive symptoms for comorbid substance use in depressive disorders (Zemestani & Ottaviani, ). A meta‐analysis of mindfulness‐based interventions for psychosis revealed that the intervention resulted in significantly reduced positive and negative psychotic symptoms when compared with TAU controls (Louise, Fitzpatrick, Strauss, Rossell, & Thomas, ).…”

Section: Treatment Of Mapmentioning

confidence: 99%

“…Chen et al, 2018). MBRP methods have been shown to decrease craving and depressive symptoms for comorbid substance use in depressive disorders (Zemestani & Ottaviani, 2016).…”

Section: Mindfulness-based Relapse Preventionmentioning

confidence: 99%

Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options

Chiang

Lombardi

et al. 2019

Human Psychopharmacology

View full text Add to dashboard Cite

Introduction Methamphetamine associated psychosis (MAP) represents a mental disorder induced by chronic methamphetamine use in a subset of users. The prevalence of the disorder has increased in several countries in Europe and Asia where methamphetamine use has increased. MAP remains difficult to distinguish from primary psychiatric disorders, especially schizophrenia, creating complications in prescribing treatment plans to patients. Design This narrative review sought to summarize difficulties related to MAP diagnosis and highlight the need for a better treatment model. Current best practices are described and potential novel therapies and future research suggested. Results Results suggest that clear biological and clinical differences appear between patients presenting with MAP and schizophrenia and that there may exist distinct subgroups within MAP itself. MAP‐specific treatment studies have been few and have focused on the use of antipsychotic medication. Antipsychotic treatment has been shown to alleviate the psychotic symptoms of MAP but produce debilitating adverse effects and fail to adequately address methamphetamine use in patients. Conclusions Continued identification of subgroups within the heterogenous MAP population may lead to better diagnosis, treatment, and outcomes for patients. Psychosocial therapies should be explored in addressing the cooccurring substance use and psychosis in the treatment of MAP.

show abstract

“…According to ancient Buddhist texts, craving leads to suffering but can be avoided through mindfulness meditation practice (Dhammacakkappavattana Sutta: Setting in Motion the Wheel of Truth [SN 56.11], 2013). More recently, mindfulness-based interventions have been used to explicitly target cravings with the aim of bringing about clinically relevant changes to behavior (e.g., Alberts, Mulkens, Smeets & Thewissen, 2010;Ruscio, Muench, Brede & Waters, 2016;Zemestani & Ottaviani, 2016). However, such interventions often comprise a range of mindfulness and non-mindfulness components, making it difficult to unequivocally attribute any changes in craving to the mindfulness-based elements of the intervention (e.g., Bricker et al, 2014;Garland, Robert-Lewis, Tronnier, Graves & Kelly, 2016;Zemestani & Ottaviani, 2016; see also Tapper, 2017).…”

Section: Mindfulness and Craving: Effects And Mechanismsmentioning

confidence: 99%

Mindfulness and craving: effects and mechanisms

Tapper

2018

Clinical Psychology Review

View full text Add to dashboard Cite

Effectiveness of Mindfulness-Based Relapse Prevention for Co-occurring Substance Use and Depression Disorders

Cited by 36 publications

References 34 publications

Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review

Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review

Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options

Mindfulness and craving: effects and mechanisms

Contact Info

Product

Resources

About